Study | Year | Country | Study design | Study period | No. of patients | Lung pathology (Adenocarcinoma/squamous cell carcinoma/other malignant tumors/benign tumors) | Heart surgery (CABG/other types of heart surgery) | Operative mortality proportions (95% CI) | Postoperative complication proportions (95% CI) |
---|---|---|---|---|---|---|---|---|---|
Li | 2019 | China | Case–control | 2009–2016 | 20 | 13/6/1/0 | 20/0 | 0.00 [0.00; 0.17] | 0.00 [0.00; 0.17] |
Yeginsu | 2018 | Turkey | Retrospective | 2014–2018 | 10 | 3/6/1/0 | 10/0 | 0.10 [0.00; 0.45] | 0.40 [0.12; 0.74] |
Kaku | 2017 | Japan | Retrospective | 2008–2013 | 18 | 13/2/0/3 | 6/12 | 0.00 [0.00; 0.19] | 0.00 [0.00; 0.19] |
Ma | 2016 | China | Retrospective | 2003–2014 | 34 | 18/16/0/0 | 34/0 | 0.00 [0.00; 0.10] | 0.32 [0.17; 0.51] |
Santavy | 2015 | Czech Republic | Retrospective | 2010–2014 | 10 | 3/0/3/4 | 6/4 | 0.00 [0.00; 0.31] | 0.10 [0.00; 0.45] |
Kovacicova | 2014 | Czech Republic | Case–control | 2002–2011 | 12 | 1/7/4/0 | 9/3 | 0.00 [0.00; 0.26] | 0.75 [0.43; 0.95] |
Zhang | 2012 | Germany | Retrospective | 1999–2007 | 30 | 6/5/1/18 | 17/13 | 0.07 [0.01; 0.22] | 0.10 [0.02; 0.27] |
Li | 2012 | China | Retrospective | 2008–2010 | 3 | 1/2/0/0 | 3/0 | 0.00 [0.00; 0.71] | 0.00 [0.00; 0.71] |
Zhang | 2009 | China | Retrospective | 2003–2008 | 7 | 2/5/0/0 | 7/0 | 0.00 [0.00; 0.41] | 0.14 [0.00; 0.58] |
Cathenis | 2009 | Belgium | Retrospective | 2000–2008 | 27 | 10/14/2/1 | 22/5 | 0.00 [0.00; 0.13] | 1.00 [0.87; 1.00] |
Prokakis | 2008 | Greece | Retrospective | 2004–2006 | 5 | 1/2/0/2 | 1/4 | 0.00 [0.00; 0.52] | 0.40 [0.05; 0.85] |
Dyszkiewicz | 2008 | Poland | Retrospective | 2001–2006 | 25 | 6/14/5/0 | 25/0 | 0.00 [0.00; 0.14] | 0.64 [0.43; 0.82] |
Schoenmakers | 2007 | Netherlands | Case–control | 1994–2005 | 43 | 17/17/9/0 | 37/6 | 0.07 [0.01; 0.19] | 0.67 [0.51; 0.81] |
Caimmi | 2006 | Italy | Retrospective | 2005–2006 | 2 | 1/1/0/0 | 2/0 | 0.00 [0.00; 0.84] | 0.00 [0.00; 0.84] |
Patane | 2002 | Italy | Retrospective | 1991–1999 | 11 | 2/7/0/2 | 6/5 | 0.00 [0.00; 0.28] | 0.00 [0.00; 0.28] |
Koksal | 2002 | Turkey | Retrospective | 2001–2002 | 2 | 0/2/0/0 | 2/0 | 0.00 [0.00; 0.84] | 0.00 [0.00; 0.84] |
Morishita | 2001 | Japan | Retrospective | 1986–2000 | 6 | 3/2/1/0 | 4/2 | 0.00 [0.00; 0.46] | 0.83 [0.36; 1.00] |
Mariani | 2001 | Netherlands | Retrospective | 1999–2000 | 3 | 2/1/0/0 | 3/0 | 0.00 [0.00; 0.71] | 0.00 [0.00; 0.71] |
Danton | 1998 | UK | Retrospective | 1990–1997 | 13 | 6/3/2/2 | 11/2 | 0.00 [0.00; 0.25] | 0.62 [0.32; 0.86] |
Voets | 1997 | Netherlands | Case–control | 1988–1995 | 24 | 8/14/2/0 | 24/0 | 0.21 [0.07; 0.42] | 0.79 [0.58; 0.93] |
Rao | 1996 | Canada | Retrospective | 1982–1995 | 30 | 10/5/6/9 | 24/6 | 0.07 [0.01; 0.22] | 0.23 [0.10; 0.42] |
Francesca | 1995 | USA | Retrospective | 1973–1990 | 21 | 11/7/3/0 | 18/3 | 0.05 [0.00; 0.24] | 0.29 [0.11; 0.52] |
Brutel | 1995 | Netherlands | Retrospective | 1979–1993 | 79 | 22/48/9/0 | 69/10 | 0.06 [0.02; 0.14] | 0.86 [0.76; 0.93] |
Terzi | 1994 | Italy | Retrospective | 1980–1993 | 10 | 2/3/3/2 | 10/0 | 0.10 [0.00; 0.45] | 0.40 [0.12; 0.74] |
Miller | 1994 | USA | Case–control | 1965–1992 | 30 | 19/8/3/0 | 23/7 | 0.07 [0.01; 0.22] | 0.50 [0.31; 0.69] |
Yokoyama | 1993 | USA | Retrospective | 1988–1992 | 11 | 6/4/1/0 | 9/2 | 0.00 [0.00; 0.28] | 0.64 [0.31; 0.89] |
Rosalion | 1993 | Australia | Retrospective | 1987–1990 | 10 | 4/5/1/0 | 10/0 | 0.00 [0.00; 0.31] | 0.80 [0.44; 0.97] |
Ulicny | 1992 | USA | Retrospective | 1980–1990 | 19 | 4/0/6/9 | 14/5 | 0.05 [0.00; 0.26] | 1.00 [0.82; 1.00] |
Canver | 1990 | USA | Retrospective | 1982–1988 | 21 | 4/4/0/13 | 18/3 | 0.05 [0.00; 0.24] | 0.10 [0.01; 0.30] |